Leuven-based health tech Lynxcare unlocks €20 million to boost clinical insights for doctors
The platform is enabling hospitals to unlock siloed, legacy data to gain insights in the real-world performance of treatments. It is the highest funding amount ever in the Belgian medical technology sector. The company works with big pharma companies such as Pfizer, AstraZeneca and J&J, but with the fresh money it wants to accelerate its international rollout by hiring 15 people.
Belgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology. The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the company’s early-stage investors Heran Partners, BTOV and PMV.
Hospitals have been digitised for a while now and have an enormous amount of data at their disposal to develop better patient care and scientific research. However, an estimated 90% of this data remains unused due to technical glitches.
Founded in 2015 by Georges De Feu and Dries Hens, the Belgian platform is enabling hospitals to unlock this siloed, legacy data to gain insights in the real-world performance of treatments and fuel clinical insights for doctors. The company uses AI and Natural Language Processing (NLP) to improve patient outcome.
The new funding will speed up the international rollout of its platform. Georges De Feu, co-founder and CEO of LynxCare said: “We’re at the forefront of a revolution where neither medical practice nor scientific convention but the actual patients and their data will define the course of healthcare.”
Dr. Christoph Kausch, managing partner at MTIP added: “The timing is perfect to partner with the European health data leader and drive forward the real- world data agenda to enable better healthcare outcomes.”
The Belgian platform has also entered into partnership with PSIH Group, the market leader in clinical business intelligence in France. Through this deal, 66% of French hospital groups can now gain access to LynxCare's software.
Related News
ArtiQ joins forces with Clario in strategic acquisition deal to transform respiratory solutions
Leuven models help unlock the dark part of space in the largest European Space Agency mission ever
QbD Chair for Precision Oncology Research in Glioblastoma extended for three years
Zeopore is making its mark in emerging green applications through catalyst optimization leadership
Leuven-based hydrogen panels become an official KU Leuven spin-off
Leuven's imec research centre targets 1950 new hires by 2035
Materialise plays crucial role in world's first-ever eye transplant
KU Leuven students win the world championships for solar cars!
Leuven-based VirusBank Platform enhances society's preparedness against future viral epidemics and pandemics
Leuven's Centre for Drug Design and Discovery (CD3) raises € 70.5 Million
International School in Leuven opens new school building for children of expats
Qaelum NV Partners with I-MED Radiology Network to Enhance Patient Dose Analysis and Incident Reporting in the ANZ Region
How can we help?
The Leuven MindGate team is at your disposal for any questions about the Leuven Innovation Region. Do you want to invest, work or study in the region? We can help you find your way.
We also facilitate collaboration and innovation between companies, knowledge institutes and government within the Leuven Innovation Region, and we are happy to guide any of these stakeholders towards innovation.